CoChat
Sign Up
Cited by 242Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment ResearchNuclear Receptors and Signaling

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study

De Pablo-Fernandez, Eduardo, Goldacre, Raph, Pakpoor, Julia, Noyce, Alastair J., Warner, Thomas T.·2018·Neurology
DOI 10.1212/wnl.0000000000005771
Open this paper in CoChat — free account

Abstract

Objective To investigate the association between type 2 diabetes mellitus (T2DM) and subsequent Parkinson disease (PD). Methods Linked English national Hospital Episode Statistics and mortality data (1999–2011) were used to conduct a retrospective cohort study. A cohort of individuals admitted for hospital care with a coded diagnosis of T2DM was constructed, and compared to a reference cohort. Subsequent PD risk was estimated using Cox regression models. Individuals with a coded diagnosis of cerebrovascular disease, vascular parkinsonism, drug-induced parkinsonism, and normal pressure hydrocephalus were excluded from the analysis. Results A total of 2,017,115 individuals entered the T2DM cohort and 6,173,208 entered the reference cohort. There were significantly elevated rates of PD following T2DM (hazard ratio [HR] 1.32, 95% confidence interval [CI] 1.29–1.35; p < 0.001). The relative increase was greater in those with complicated T2DM (HR 1.49, 95% CI 1.42–1.56) and when comparing younger individuals (HR 3.81, 95% CI 2.84–5.11 in age group 25–44 years). Conclusions We report an increased rate of subsequent PD following T2DM in this large cohort study. These findings may reflect shared genetic predisposition and/or disrupted shared pathogenic pathways with potential clinical and therapeutic implications.

Overview

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000005771

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 9 references

Research works printed but not linked: 1

  1. National Institute for Health and Care Excellence. Parkinson's Disease in Adults. NICE Guideline NG71 [online]. Available at: nice.org.uk/guidance/NG71. Accessed August 1, 2017.

Cited by

Sorted by citations

Items 201–242 of 242

Related

See all

Metadata

Authors
De Pablo-Fernandez, E., Goldacre, R., Pakpoor, J., Noyce, A. J., & Warner, T. T.
Affiliations
  • From the Reta Lila Weston Institute of Neurological Studies, Department of Molecular Neurosciences (E.D.P.-F., A.J.N., T.T.W.), and Queen Square Brain Bank for Neurological Disorders (E.D.P.-F., T.T.W.), UCL Institute of Neurology, London; Unit of Health-Care Epidemiology (R.G., J.P.), Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Population Health, University of Oxford; and Preventive Neurology Unit (A.J.N.), Wolfson Institute of Preventive...
  • Queen Mary University of London (GB)
ORCID
Venue
Neurology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2018-07-10
Volume
91
Issue
2
Pages
e139-e142
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
DOI
10.1212/wnl.0000000000005771
OpenAlex
W2807806732
Cited by
242
References
9
Citations by year
2026: 23 · 2025: 21 · 2024: 36 · 2023: 28 · 2022: 29 · 2021: 35 · 2020: 34 · 2019: 26 · 2018: 9
FWCI
17.62
Type
journal article
Language
en
Open access
closed
Locations
  • Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • Prothena
  • Barts Charity (MGU0364)
  • National Institute for Health and Care Research (RNC/035/02)
  • Parkinson's UK
  • Brain Research Trust
  • University College London
  • University of Oxford
  • Britannia Pharmaceuticals
  • Medical Research Council (MR/L023784/2, MR/L023784/1)
  • NIHR Oxford Biomedical Research Centre
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
type 2 diabetes, Parkinson's disease, risk factors, complicated diabetes, young adults, pathogenic pathways
MeSH terms
Adult, Age Factors, Aged, Diabetes Mellitus, Type 2, England, Female, Humans, Male, Middle Aged, Parkinson Disease, Retrospective Studies, Risk Factors, Comorbidity, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review